GBIO - Generation Bio Co. - SEC Form 4 Insider Trading Screener
7 results - 
- 
- 
- 
- 
- 
- - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2020-06-16 | GBIO | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% | P - Purchase | $19.00 | +1,100,000 | 2,112,546 | +109% | +$20,900,000 | |||||
| D | 2020-06-16 | GBIO | Invus Public Equities, L.P. | 10% | P - Purchase | $19.00 | +800,000 | 2,814,191 | +40% | +$15,200,000 | |||||
| D | 2020-06-16 | GBIO | Rowland Charles A Jr | Dir | P - Purchase | $19.00 | +30,000 | 80,627 | +59% | +$570,000 | |||||
| D | 2020-06-16 | GBIO | Casdin Capital, LLC | 10% | P - Purchase | $19.00 | +650,000 | 1,611,215 | +68% | +$12,350,000 | |||||
| D | 2020-06-16 | GBIO | Zone Healthcare Holdings, LLC | Member of Group Owning 10%, 10% | P - Purchase | $19.00 | +400,000 | 5,356,457 | +8% | +$7,600,000 | |||||
| D | 2020-06-16 | GBIO | Seybold William | Member of Group Owning 10%, 10% | P - Purchase | $19.00 | +400,000 | 5,356,457 | +8% | +$7,600,000 | |||||
| D | 2020-06-16 | GBIO | Flynn James E | Possible Member of 10% Group, 10% | P - Purchase | $19.00 | +225,000 | 1,186,215 | +23% | +$4,275,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |